Lipids in Parenteral Nutrition: Benefits in Critically Ill Patients?

  • I. Kelbel
  • P. L. Radermacher
  • H. Suger-Wiedeck


Currently, total parenteral nutrition (TPN) is used for nutritional support in a wide variety of patients when the enteral route cannot be used. Over the past 30 years, long-chain triglycerides (LCT) derived from soybean or safflower oil have been the source of lipid emulsions for parenteral nutrition. Traditionally, lipid emulsions are included in parenteral nutrition regimes both as part of energy supply and as a source of essential fatty acids. It has become obvious during the last two decades that the amount and type of long-chain fatty acids consumed in the diet can profoundly influence biological responses. Therefore, efforts to further develop and optimize lipid emulsions have focused on replacing part of the LCT by medium-chain triglycerides (MCT). As a result, the physical MCT/LCT mixture is a well proven concept in TPN regimes. Mixed triglyceride molecules obtained by interesterifying MCT and LCT — so called structured triglycerides — are the latest result of this chain of development.


Parenteral Nutrition Total Parenteral Nutrition Lipid Emulsion Structure Triglyceride Parenteral Nutrition Regime 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Holman R, Johnson S, Hatch T (1982) A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr 35: 617–623PubMedGoogle Scholar
  2. 2.
    Radermacher P, Grote H, Herbertz L, Reinauer H (1982) Effect of lipid infusions on tri-glyceride and protein metabolism. Infusionther Klin Ernahr 9: 279–85Google Scholar
  3. 3.
    Nussbaum M, Li S, Bower R, McFadden D, Dayal R, Fischer J (1992) Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio. J Parenter Enteral Nutr 16: 106–109CrossRefGoogle Scholar
  4. 4.
    Roulet M, Wiesel P, Chapuis G, Carpentier Y (1993) Effects of intravenously infused egg phospholipids on lipid and lipoprotein metabolism in postoperative trauma. J Parenter Enteral Nutr 17: 107–112CrossRefGoogle Scholar
  5. 5.
    Fisher GW, Hunter KW, Wilson SR, Mease D (1980) Diminished bacterial defense with Intralipid. Lancet ii: 819–820Google Scholar
  6. 6.
    Sedman PC, Somers SS, Ramsden CW, Brennan TG, Guillou PJ (1991) Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg 78: 1396–1399PubMedCrossRefGoogle Scholar
  7. 7.
    Waitzberg DL, Bellinati-Pires R, Salgado MM, et al (1997) Effect of total parenteral nutrition with different lipid emulsions on human monocyte and neutrophil functions. Nutrition 13: 128–132PubMedCrossRefGoogle Scholar
  8. 8.
    Adolph M, Hailer S, Eckart J (1995) Serum phospholipid fatty acids in severely injured patients on total parenteral nutrition with medium chain/long chain triglyceride emulsions. Ann Nutr Metab 39: 251–260PubMedCrossRefGoogle Scholar
  9. 9.
    Jansing P, Reinauer H (1978) Human catabolism of medium and long chain triglycerides after intravenous infusion. Infusionsther Klin Ernähr 5: 26–32PubMedGoogle Scholar
  10. 10.
    Carpentier YA, Dubois DY, Siderova VS, Richelle M (1994) Exogenous lipids and hepatic function. In: Kinney JM, Tucker HN (eds) Organ Metabolism and Nutrition. Raven Press, New York, pp 349–367Google Scholar
  11. 11.
    Sobrado J, Moldawer LL, Pomposelli JJ, Mascioli EA (1985) Lipid emulsions and reticuloendothelial system function in healthy and burned guinea pigs. Am J Clin Nutr 42: 855–863PubMedGoogle Scholar
  12. 12.
    Smyrniotis VE, Kostopanagiotou GG, Arkadopoulos NF, et al (2001) Long-chain versus medium-chain lipids in acute pancreatitis complicated by acute respiratory distress syndrome: effects on pulmonary hemodynamics and gas exchange. Clin Nutr 20: 139–143PubMedCrossRefGoogle Scholar
  13. 13.
    Radermacher P, Santak B, Strobach H, Schrör K, Tarnow J (1992) Fat emulsions containing medium chain triglycerides in patients with sepsis syndrome: Effects on pulmonary hemodynamics and gas exchange. Intensive Care Med 18: 231–234Google Scholar
  14. 14.
    Suchner U, Katz DP, Furst P, et al (2001) Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis. Crit Care Med 29: 1569–1574PubMedCrossRefGoogle Scholar
  15. 15.
    Sandström R, Hyltander A, Körner U, Lundholm K (1995) Structured triglycerides were well tolerated and induced increased whole body fat oxidation compared with long-chain triglycerides in postoperative patients. J Parenter Enteral Nutr 19: 381–386CrossRefGoogle Scholar
  16. 16.
    Lindgren BF, Ruokonen E, Magnusson-Borg K, Takala J (2001) Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomised controlled trial. Clin Nutr 20: 43–48PubMedCrossRefGoogle Scholar
  17. 17.
    Kruimel JW, Naber TH, van der Vliet JA, Carneheim C, Katan MB, Jansen JB (2001) Par-enteral structured triglyceride emulsion improves nitrogen balance and is cleared faster from the blood in moderately catabolic patients. J Parenter Enteral Nutr 25: 237–244CrossRefGoogle Scholar
  18. 18.
    Rabl H, Ratschek M, Khoschsorur G, et al (1997) Limitation of intestinal reperfusion injury in the rat by vitamin treatment. Med Sci Res 25: 315–318Google Scholar
  19. 19.
    Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G (2000) Antioxidant status of surgical patients receiving TPN with an co-3-fatty acid-containing lipid emulsion supplemented with a-tocopherol. Clin Nutr 19: 177–184PubMedCrossRefGoogle Scholar
  20. 20.
    Dutot G, Melin C (1991) Assessment of lipid peroxidation during lipid infusion: influence of fatty acid composition of fat emulsion. Clin Nutr 10 (Suppl 2): 50Google Scholar
  21. 21.
    Gracia de Lorenzo A, Denia R, Martinez Ratero S, et al (2000) Randomised, double-blinded study in severely burned patients under short term total parenteral nutrition (TPN) with a new olive-oil based lipid emulsion vs. MCT/LCT lipid emulsion. Clin Nutr 19 (Suppl 1): 177Google Scholar
  22. 22.
    Arborati M, Ninio E, Chapman MJ, Sultan F (1997) Comparison of lipoperoxide content and lipoperoxidability in parenteral fat emulsions with different triglyceride content. Clin Nutr 16 (Suppl 2): 018Google Scholar
  23. 23.
    Granato D, Blum S, Rössle C, Le Boucher J, Malnoe A, Dutot G (2000) Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enteral Nutr 24: 113–118CrossRefGoogle Scholar
  24. 24.
    Moussa M, Boucher LE, Garcia J, et al (2000) In vivo effects of olive oil-based lipid emulsion on lymphocyte activation in rats. Clin Nutr 19: 49–54PubMedCrossRefGoogle Scholar
  25. 25.
    Dyerberg J, Bang HO, Hjorne N (1975) Fatty acid composition of the plasma lipids in Greenland eskimos. Am J Clin Nutr 28: 958–966PubMedGoogle Scholar
  26. 26.
    Weber PC, Fischer S, von Schacky C, et al (1986) Dietary omega-3 polyunsaturated fatty acids and eiosanoid formation in man. In: Simopoulos AP, Kifer RR, Martin RE (eds) Health Effects of Polyunsaturated Acids in Seafoods. Academic Press, Orlando, pp: 49–60Google Scholar
  27. 27.
    Weber PC (1989) Clinical studies on the effect of n-3 fatty acids on cells and eicosanoids in cardiovascular system. J Intern Med 225: 61–68Google Scholar
  28. 28.
    Fürst P (1998) Old and new substrates in clinical nutrition. J Nutr 128: 789–796PubMedGoogle Scholar
  29. 29.
    Grimble RF (1998) Dietary lipids and the inflammatory response. Proc Nutr Soc 57: 535–542PubMedCrossRefGoogle Scholar
  30. 30.
    Ross JA, Moses AGW Fearon KCH (1999) The anti-catabolic effects of n-3 fatty acids. Curr Opin Clin Nutr Met Care 2: 219–226CrossRefGoogle Scholar
  31. 31.
    Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63: 116–122PubMedGoogle Scholar
  32. 32.
    Mascioli EA, Leader L, Flores E, Trimbo S, Bistrian B, Blackburn G (1988) Enhanced survival to endotoxin in guinea pigs fed iv fish oil emulsion. Lipids 23: 623–625PubMedCrossRefGoogle Scholar
  33. 33.
    Mossman TR, Sad S (1996) The expanding universe of T-cell subsets: Thl, Th2 and more. Immunol Today 17: 138–146CrossRefGoogle Scholar
  34. 34.
    Pscheidl E, Schywalsky M, Tschaikowski K, Böke-Pröls T (2000) Fish oil supplemented par-enteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 28: 1489–1496PubMedCrossRefGoogle Scholar
  35. 35.
    Fritsche KL, Shahabazian LM, Feng C, Berg JN (1997) Dietary fish oil reduces survival and impairs bacterial clearance in C3H/Hen mice challenged with Listeria monocytogenes. Clin Sci (Lond) 92: 95–101Google Scholar
  36. 36.
    Kelbel I, Koch T, Prechtl A, et al (1999) Effects of parenteral application of fish oil versus soy oil emulsion on bacterial clearance functions. Infusionsther Transfusionsmed 26: 226–232Google Scholar
  37. 37.
    Cukier C, Waitzberg DL, Logullo AF, et al (1999) Lipid and lipid-free total parenteral nutrition: differential effects on macrophage phagocytosis in rats. Nutrition 15: 885–889PubMedCrossRefGoogle Scholar
  38. 38.
    Watanabe S, Hayashi H, Onozaki K, Okuyama H (1991) Effect of dietary alpha-linolenate/ linoleate balance on lipopolysaccharide-induced tumor necrosis factor production in mouse macrophages. Life Sci 28: 2013–2020CrossRefGoogle Scholar
  39. 39.
    Alexander JW, Saito H, Trocki 0, Ogle CK (1986) The importance of lipid type in the diet after burn injury. Ann Surg 204: 1–8PubMedCrossRefGoogle Scholar
  40. 40.
    Cerra FB, Alden PA, Negro F, et al (1988) Sepsis and exogenous lipid modulation. J Parenter Enteral Nutr 12 (6 Suppl): 63S - 68SCrossRefGoogle Scholar
  41. 41.
    Ertel W, Morrison MH, Ayala A, Chaudry IH (1993) Modulation of macrophage membrane phospholipids by n-3 polyunsaturated fatty acids increases interleukin-1 release and prevents suppression of cellular immunity following hemorrhagic shock. Arch Surg 128: 15–21PubMedCrossRefGoogle Scholar
  42. 42.
    Lanza-Jacoby S, Flynn JT, Miller S (2001) Parenteral supplementation with fish oil emulsion prolongs survival and improves lymphocyte function during sepsis. Nutrition 17: 112–116PubMedCrossRefGoogle Scholar
  43. 43.
    Fernades G, Bysani C, Venkatramen JT, Tomar V, Zhao W (1994) Increased TGF-/3 and decreased oncogene expression by w-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152: 5979–5987Google Scholar
  44. 44.
    Shayevitz JR, Miller C, Johnson KJ, Rodriguez JL (1995) Multiple organ dysfunction syndrom: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock 4: 389–396PubMedCrossRefGoogle Scholar
  45. 45.
    Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock; Relation to multiple-system organ failure and mortality. Chest 103: 565–575Google Scholar
  46. 46.
    Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24: 1125–1128PubMedCrossRefGoogle Scholar
  47. 47.
    Abraham E (1991) Physiological stress and cellular ischemia: Relationship to immunosuppression and susceptibility to infection. Crit Care Med 19: 613–618PubMedCrossRefGoogle Scholar
  48. 48.
    Breil I, Koch T, Heller A, et al (1996) Alteration of n-3 fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction. Crit Care Med 24: 1893–1902PubMedCrossRefGoogle Scholar
  49. 49.
    Koch T, Heller A, Breil I, van Ackern K, Neuhof H (1995) Alterations of pulmonary capillary filtration and leukotriene-synthesis, due to infusion of a lipid emulsion enriched with omega-3 fatty acids. Clin Intensive Care 6: 112–120Google Scholar
  50. 50.
    Druml W, Fischer M, Ratheiser K (1998) Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. J Parenter Enteral Nutr 22: 217–223CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • I. Kelbel
  • P. L. Radermacher
  • H. Suger-Wiedeck

There are no affiliations available

Personalised recommendations